CYBO

About:

CYBO is a technological business that designs and develops cells with artificial intelligence for medical researchers and equipment.

Website: https://www.cybo.jp/

Twitter/X: kk_cybo

Top Investors: Incubate Fund, JAFCO

Description:

CYBO applies AI to give cells an increase in intelligence. Their cell-measuring technology is made to identify and comprehend cells. By combining hardware like high-speed imaging with software like artificial intelligence and image processing, they can perform cell analysis. They provide a framework that can be used for the manufacture of medications and food items in addition to the diagnosis and treatment of illnesses. Its cell measurement technology is intended to better understand and distinguish cells. This is the foundational technology that they are proud to offer to the world. Furthermore, they have advanced cell analysis by combining software technologies such as AI and image processing with hardware technologies such as high-speed imaging.

Total Funding Amount:

460M JPY

Headquarters Location:

Tokyo, Tokyo, Japan

Founded Date:

2018-07-17

Founders:

Nao Nitta

Number of Employees:

11-50

Last Funding Date:

2023-06-13

IPO Status:

Private

Industries:

© 2025 bioDAO.ai